Maxine Sun

机构：Dana-Farber Cancer Institute · ORCID：0000-0002-7116-8674

发表论文 996 篇 · 总被引 25895 次 · h-index 82

代表论文

• Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma (2025 · Cancer Cell · 被引 9)
• Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK Biobank (2025 · ESMO Open · 被引 6)
• 2613MO Identifying biomarkers of response to first-line nivolumab plus ipilimumab therapy in patients with metastatic clear cell renal cell carcinoma (mccRCC) enrolled in the COSMIC 313 trial (2025 · Annals of Oncology · 被引 2)
• Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis (2025 · ESMO Open · 被引 1)
• 5Integrative clinical, genomic, transcriptomic, and immunopathologic characterization of circulating KIM-1 in metastatic RCC (2025 · The Oncologist · 被引 1)
• 6Lower checkpoint gene expression is associated with primary resistance to nivolumab-ipilimumab combination in advanced renal cell carcinoma (2025 · The Oncologist · 被引 1)